> Roll-out of the first vaccine dose now needs to be accelerated globally to help overcome this terrible disease. In a publication in the International Journa

> Roll-out of the first vaccine dose now needs to be accelerated globally to help overcome this terrible disease. In a publication in the International Journal of Antimicrobial Agents titled “SARS-CoV-2: fear versus data” (March 19th 2020), the researchers indicate that “there does not seem to be a significant difference between the mortality rate of SARS-CoV-2 in OECD countries and that of common coronaviruses”. Furthermore, according to their analysis, “SARS-CoV-2 infection cannot be described as being statistically more severe than infection with other coronaviruses in common circulation. […] Finally, in OECD countries, SARS-CoV-2 does not seem to be deadlier than other circulating viruses.”